oral glp-1 medications fda approved In a major milestone for obesity care, the has Wegovy® as the first receptor agonist for chronic weight management in adults with obesity or overweight and related conditions FDA Grants Speedy Approval to

SGLT2 inhibitors are now authorised for the treatment of chronic kidney disease and heart failure in individuals with or without T2DM [1, 2]

ClinicalTrials.gov entries (e.g., NCT05931367 for TRIUMPH-4)

( Ref: Conclusion: Small Changes, Big Impact You dont need expensive medications to support your body's GLP-1 hormone naturally

Mechanism of Action Glucose Homeostasis: Enhances insulin secretion, suppresses glucagon release Gastric Motility: Delays emptying, promotes satiety signals Cardiovascular: Improves endothelial function, reduces inflammation Neuroprotection: Activates survival pathways, reduces neuroinflammation Renal Protection: Reduces albuminuria, preserves kidney function Hepatic: Improves steatosis, reduces liver inflammation Research Advantages Extended Half-Life: Hours vs